  Structure-based virtual screening (SBVS) is a promising in silico technique
that integrates computational methods into drug design. An extensively used
method in SBVS is molecular docking. However, the docking process can hardly be
computationally efficient and accurate simultaneously because classic mechanics
scoring function is used to approximate, but hardly reach, the quantum
mechanics precision in this method. In order to reduce the computational cost
of the protein-ligand scoring process and use data driven approach to boost the
scoring function accuracy, we introduce a docking-based SBVS method and,
furthermore, a deep learning non-docking-based method that is able to avoid the
computational cost of the docking process. Then, we try to integrate these two
methods into an easy-to-use framework, ParaVS, that provides both choices for
researchers. Graph neural network (GNN) is employed in ParaVS, and we explained
how our in-house GNN works and how to model ligands and molecular targets. To
verify our approaches, cross validation experiments are done on two datasets,
an open dataset Directory of Useful Decoys: Enhanced (DUD.E) and an in-house
proprietary dataset without computational generated artificial decoys
(NoDecoy). On DUD.E we achieved a state-of-the-art AUC of 0.981 and a
state-of-the-art enrichment factor at 2% of 36.2; on NoDecoy we achieved an AUC
of 0.974. We further finish inference of an open database, Enamine REAL
Database (RDB), that comprises over 1.36 billion molecules in 4050 core-hours
using our ParaVS non-docking method (ParaVS-ND). The inference speed of
ParaVS-ND is about 3.6e5 molecule / core-hour, while this number of a
conventional docking-based method is around 20, which is about 16000 times
faster. The experiments indicate that ParaVS is accurate, computationally
efficient and can be generalized to different molecular.
